Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, ...

Maravai LifeSciences (NASDAQ:MRVI) said on Wednesday that based on preliminary year-end results, the company expects to ...

Craig-Hallum analyst Matt Hewitt assigned a Buy rating to the stock today. The company’s shares closed last Wednesday at $6.13.Stay Ahead of ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Maravai LifeSciences Holdings said Wednesday it expects to report full-year revenue for 2024 near the midpoint of its most recent outlook. The San Diego company has guided for full-year revenue ...

Jane Street Group LLC decreased its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by ...

Maravai Lifesciences Holdings, Inc. (Maravai) has announced its preliminary unaudited 2024 revenue, expecting to report total ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...